Skip to main content
Clinical Trials/ISRCTN00788389
ISRCTN00788389
Completed
未知

A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS)

orth Bristol NHS Trust (UK)0 sites410 target enrollmentSeptember 20, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
orth Bristol NHS Trust (UK)
Enrollment
410
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2017 protocol in https://www.ncbi.nlm.nih.gov/pubmed/28412960 2020 results in https://pubmed.ncbi.nlm.nih.gov/32622397/ (added 06/07/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32901611/ (added 10/09/2020) 2020 cost-effectiveness analysis in https://pubmed.ncbi.nlm.nih.gov/32558178/ (added 08/02/2021)

Registry
who.int
Start Date
September 20, 2013
End Date
December 31, 2017
Last Updated
5 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
orth Bristol NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Adult men over the age of 18 suitable for TURP, either in urinary retention or with bothersome lower urinary tract symptoms (LUTS), secondary to BPO.

Exclusion Criteria

  • Patients with:
  • 1\. Neurogenic lower urinary tract dysfunction (LUTS)
  • 2\. Prostate cancer
  • 3\. Previous prostate or urethral surgery
  • Added 08/12/2017:
  • 4\. A PSA outside of the normal age\-related range and who have not had prostate cancer excluded
  • 5\. Men who are unable to give informed consent or complete trial documentation

Outcomes

Primary Outcomes

Not specified

Similar Trials